Financials

  • Market Capitalization 21.15 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.05
Rapporto prezzo/fatturato
-280.95

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4592
ALGS
Aligos Therapeutics, Inc. - Common stock
6.17 USD-2.99%-0.64%+16.42%-36.98%21.37 M USD
4595
VYNE
VYNE Therapeutics Inc. - Common Stock
0.71 USD+7.58%+7.58%+9.23%-46.21%23.68 M USD
4599
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.71 USD+3.04%+1.88%+17.83%-13.69%21.66 M USD
4602
SKYE
Skye Bioscience, Inc. - Common Stock
0.60 USD-9.09%-16.67%-24.05%-25.00%21.09 M USD

Notizie